Ublituximab-Xiyl 150 mg/6 mL Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 150 mg/6 mL
Reference Brands: Briumvi (USA/EU)
Category: Neurology
ublituximab-xiyl is a CD20-directed monoclonal antibody that targets B-cells responsible for nerve damage in multiple sclerosis. It helps reduce relapses and slow disability progression in adults with relapsing forms of MS. Administered as an intravenous infusion, it offers a targeted approach with fewer infusion sessions compared to some other MS therapies.
Ublituximab-Xiyl — third party manufacturing & bulk supply
Ublituximab-Xiyl 150 mg/6 mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Ublituximab-Xiyl is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Ublituximab-Xiyl listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Ublituximab-Xiyl →Frequently Asked Questions
Related Products
Valproic Acid
Strength:
125 mg/mL, 200 mg, 250 mg, 300 mg, 500 mg, 100 mg/mL
Form: Tablet / Capsule/ Injection / Oral syrup
Reference Brands: Depakene (USA), Depakine (EU/LATAM), Valprol (India)
View Details
Quick Response Guaranteed | Verified Suppliers
